Why Cannabinoids Can Both Prevent and Cause Vomiting: The Hyperemesis Paradox
A review explored the paradox of cannabinoid hyperemesis syndrome, where chronic cannabis use causes cyclical vomiting despite cannabinoids being established anti-nausea drugs, proposing multiple pharmacokinetic and pharmacodynamic mechanisms.
Quick Facts
What This Study Found
Cannabinoids are clinically used as anti-nausea medications (preventing chemotherapy-induced vomiting through CB1 receptor stimulation), making the recently recognized cannabinoid hyperemesis syndrome (CHS) a paradox.
CHS is characterized by repeated cyclical vomiting and compulsive hot water bathing in chronic cannabis users. Though initially considered rare, increasing case reports suggested it was more common than thought.
The review proposed multiple potential mechanisms:
Pharmacokinetic: THC long half-life and fat solubility leading to accumulation, individual variation in metabolism/excretion, and buildup of emetogenic (vomiting-causing) metabolites.
Pharmacodynamic: THC switching from partial agonist to antagonist at certain levels, CB1 receptor desensitization or downregulation with chronic exposure, alterations in endocannabinoid concentrations, and differential effects in the brain versus the gut.
The review also noted that chronic exposure may not be necessary to trigger vomiting but is required for the intensity of emesis.
Key Numbers
International case reports were increasingly being published at the time. Multiple pharmacokinetic and pharmacodynamic mechanisms were proposed.
How They Did This
Narrative review examining basic science mechanisms that could explain cannabinoid-induced hyperemesis, integrating pharmacokinetic, pharmacodynamic, and clinical data.
Why This Research Matters
Understanding why an anti-emetic drug can paradoxically cause vomiting has implications for both clinical use of cannabinoid medications and for the millions of chronic cannabis users who could potentially develop this syndrome.
The Bigger Picture
CHS has become increasingly recognized since this review. Understanding the mechanism is important because CHS can cause severe dehydration, electrolyte imbalances, and repeated emergency department visits, and is often initially misdiagnosed.
What This Study Doesn't Tell Us
No single mechanism has been definitively established. The review was based on case reports and basic science reasoning rather than direct experimental testing of proposed mechanisms. CHS prevalence was uncertain.
Questions This Raises
- ?Which mechanism is primary?
- ?Why do only some chronic users develop CHS?
- ?Why does hot water bathing provide relief?
- ?Can CHS be predicted or prevented in susceptible individuals?
Trust & Context
- Key Stat:
- Anti-nausea drug paradoxically causes cyclical vomiting in chronic users
- Evidence Grade:
- Narrative review proposing mechanistic explanations based on basic science and clinical observations. No mechanism has been definitively proven.
- Study Age:
- Published in 2010. CHS has since been widely recognized as a clinical entity, with clearer diagnostic criteria and management guidelines developed.
- Original Title:
- Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical Recognition to Basic Science Mechanisms.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 3(7), 2163-2177 (2010)
- Authors:
- Darmani, Nissar A(2)
- Database ID:
- RTHC-00405
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is cannabinoid hyperemesis syndrome?
CHS is a condition in chronic cannabis users characterized by episodes of severe nausea and vomiting that occur in cycles, often accompanied by compulsive hot water bathing (which temporarily relieves symptoms). The only definitive treatment is stopping cannabis use.
If cannabis prevents nausea, how can it also cause vomiting?
The paradox may involve receptor desensitization (receptors becoming less responsive to chronic stimulation), accumulation of vomiting-inducing metabolites, or different effects in the brain versus the gut. The exact mechanism remains debated.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- why-does-weed-make-you-hungry-munchies
- why-does-weed-make-food-taste-better
Cite This Study
https://rethinkthc.com/research/RTHC-00405APA
Darmani, Nissar A. (2010). Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical Recognition to Basic Science Mechanisms.. Pharmaceuticals (Basel, Switzerland), 3(7), 2163-2177.
MLA
Darmani, Nissar A. "Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical Recognition to Basic Science Mechanisms.." Pharmaceuticals (Basel, 2010.
RethinkTHC
RethinkTHC Research Database. "Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical R..." RTHC-00405. Retrieved from https://rethinkthc.com/research/darmani-2010-cannabinoidinduced-hyperemesis-a-conundrumfrom
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.